Titled the Medical Technology Market in Europe 2014-2018, the report forecasts the Medical Technology Market in Europe to grow at a CAGR of 4.50 percent over the period 2013-2018.
The Lateral approach adds to the Interventional Spine® family of Opticage™ Expandable Interbody Fusion Devices previously cleared for TLIF
Silk Road Medical's ROADSTER IDE Study points to low 30 day stroke rate using novel flow-reversal approach to carotid angioplasty and stenting.
CE Mark approval for Nellcor™ PM100N Bedside SpO2 Patient Monitoring System brings the latest in bedside pulse oximetry to the home healthcare.
Cook Medical is launching the Perc NGage® and Perc NCompass® nitinol stone extractors for performing percutaneous nephrolithotomy (PCNL).
Zyga Technology, Inc., has announced the first patient enrollment in DUET, a U.S. multicenter single-arm study to investigate its Glyder device to alleviate facet joint pain.
Available in Europe since 2010, IlluminOss will soon be seeing commencement of US studies into its novel photodynamic bone stabilization system.
A retrospective data analysis from a study into St. Jude's CardioMEMS™ HF monitoring sensor shows significant a reduction in 30-day hospital readmission rates for patients age 65 and older.
New Gel-Block 10x offers 10 pledgets in a vial as a configuration that enhances value and customer ease-of-use.
Covidien plc has gained U.S. FDA 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter.
It's about as far away from medical devices as we ever get, but lab attire for women looks like it's going "designer", leaving the shapeless white lab coat with the burn marks and stains for the chaps.
History suggests that repair of horizontal cleavage tears in the knee meniscus is both tricky and of questionable value. A new study should bring our knowledge up to date.
U.S. medical device company Royal Oak Medical Devices has been testing its so-called rep-less sales model. Now it's to be rolled out across the country.
Boston Scientific reports that its SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System met its primary endpoint in the first successful U.S. pivotal trial of a bioabsorbable polymer stent.
FDA clears new device for use along with a standard colonoscope to improve visibility in areas behind folds in colon wall.